Simiao Niu, an assistant professor of biomedical engineering in the School of Engineering at Rutgers-New Brunswick, has played a crucial role in the development of the kind of device that he dreamed of: a unique prototype of what he and his research collaborators are calling a “living bioelectronic” designed to treat psoriasis.
LifeBridge Health has named Sharon Hendricks as chief administrative officer of Levindale Hebrew Geriatric Center and Hospital, a 330-licensed bed facility that offers several types of care services, including a long-term residential facility, a sub-acute rehabilitation unit and a specialty hospital with a high-intensity care unit.
The UNM Comprehensive Cancer Center is partnering with Northern Arizona University, New Mexico State University and the Burrell College of Osteopathic Medicine, which is located on NMSU’s campus in Las Cruces, to connect emerging cancer disparities researchers with mentors to continue developing these scholars.
Ochsner Health is proud to recognize two recent professional accomplishments of Dr. Gerald “Gerry” Cvitanovich, chief strategy officer of Ochsner Urgent Care and Occupational Health.
Cedars-Sinai has appointed Andrew Geller, MD, and Michael Nurok, MB, ChB, PhD, as co-chairs of the Department of Anesthesiology.
Evidence that Word Trade Center (WTC) responders during 9/11 and its aftermath have since suffered poorer brain health than others not exposed to WTC toxins has mounted in recent years. A new study led by Stony Brook University researchers that evaluates more than 5,000 WTC responders indicates that those who had more exposures to WTC-related toxins have dementia at a higher rate than other responders with fewer WTC-related toxic exposures.
Cardiovascular disease (CVD) is the leading cause of death worldwide, accounting for approximately one in every three deaths, with more than 20 million deaths reported in 2021 according to a 2024 World Heart Federation report.
The study reported in the journal Nature provides a mechanistic explanation for the “obesity paradox” — that obesity can contribute to cancer progression but also improve response to immunotherapy.
Significant progress has been made in the development of a small device, about the size of a vitamin pill, that can be swallowed and passed through the gastrointestinal tract to sample and help identify the full inventory of microbiome bacteria in an individual.
The Norwegian Academy of Science and Letters announced the 2024 Kavli Prize Laureates, recognizing groundbreaking science for the discovery and characterization of extra-solar planets and their atmospheres; foundational research integrating synthetic nanoscale materials for biomedical use; and the localization of areas in the brain specialized for face recognition and processing.
The American Society for Radiation Oncology (ASTRO) applauded today’s introduction of bipartisan federal legislation to address critical flaws in the prior authorization process. “The prior authorization system in its current form is ineffective and harmful to patients, creating unnecessary delays to lifesaving cancer treatments and distress for the people who need them,” said Jeff M. Michalski, MD, MBA, FASTRO, Chair of the ASTRO Board of Directors.
The University of Texas MD Anderson Cancer Center and Sibylla Biotech today announced a strategic collaboration agreement to discover and develop novel small-molecule cancer therapies known as folding interfering degraders (FIDs), which disrupt the proper folding of target proteins and lead to their degradation.
A recent study found that adding anlotinib to the standard STUPP regimen for glioblastoma patients could improve outcomes. The trial, involving 33 newly diagnosed patients, reported a median progression-free survival (PFS) of 10.9 months and a median overall survival (OS) of 17.4 months. This promising result suggests a potential new approach for treating this aggressive brain cancer.
How can an animal virus turn into a human disease? Between the ongoing COVID-19 pandemic and the looming concern of avian flu, the question is an urgent one. Tyler Starr, PhD, has received a prestigious Searle Scholar Award to look for answers.
Knee osteoarthritis (OA) is a common cause of pain and joint stiffness. And while physical activity is known to ease symptoms, only one in 10 people regularly exercise.
Harvard Medical School researchers are studying one of the most mysterious — and most essential — senses
For nearly two decades, how kidney cancer becomes resistant to rapalog drugs has baffled the scientific community. Now a study by researchers at UT Southwestern Medical Center’s Kidney Cancer Program sheds light.
Researchers at Brigham and Women’s Hospital and Dana-Farber Cancer Institute found significant uptake and scalability in phone-based “PATH” intervention to improve psychological well-being in blood cancer patients, according to new study in JNCCN.
This marks the second consecutive year St. Bernard Parish Hospital has earned the honor of being named a Great Community Hospital.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
